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1078–5Introduction. Inflammation is a recognized risk factor for the vulnerable atherosclerotic plaque. The aim of this study was
to explore whether there is a difference in the degree of Magnetic Resonance (MR) defined inflammation using Ultra Small
Super-Paramagnetic Iron Oxide (USPIO) particles, within carotid atheroma in completely asymptomatic individuals and
the asymptomatic carotid stenosis in a cohort of patients undergoing coronary artery bypass grafting (CABG).
Methods. 10 patients awaiting CABG with asymptomatic carotid disease and 10 completely asymptomatic individuals
with no documented coronary artery disease underwent multi-sequence MR imaging before and 36 hours post USPIO
infusion. Images were manually segmented into quadrants and signal change in each quadrant, normalised to adjacent
muscle signal, was calculated following USPIO administration.
Results. The mean percentage of quadrants showing signal loss was 94% in the CABG group, compared to 24% in the
completely asymptomatic individuals (p< 0.001). The carotid plaques from the CABG patients showed a significant mean
signal intensity decrease of 16.4% after USPIO infusion (95% CI 10.6% to 22.2%; p< 0.001). The truly asymptomatic
plaques showed a mean signal intensity increase (i.e. enhancement) after USPIO infusion of 8.4% (95% CI 2.6% to 14.2%;
p¼ 0.007). The mean signal difference between the two groups was 24.9% (95% CI 16.7% to 33.0%; p< 0.001).
Conclusions. These findings are consistent with the hypothesis that inflammatory atheroma is a systemic disease. The
carotid territory is more likely to take up USPIO if another vascular territory is symptomatic.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Search Terms: MRI [120]; Stroke prevention [12]; Other cerebrovascular disease/stroke [13].Introduction
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884/000392+ 07 $34.00/0  2007 European Society for Vasculaevents.1 Advances in the understanding of plaque biol-
ogy and the shortcomings of angiography have stimu-
lated the development of novel imaging techniques to
identify and quantify inflammation within carotid dis-
ease. It has been possible to image carotid plaque in-
flammation with Ultra small Super-Paramagnetic Iron
Oxide (USPIO) enhanced MR imaging in humans.2
The use of a USPIO agent e Sinerem (Guerbet,
France), has allowed the direct visualisation of macro-
phage infiltration of carotid atheroma in-vivo.2e4 US-
PIO particles are taken up by activated macrophages
in vulnerable plaques and when clumped inr Surgery. Published by Elsevier Ltd. All rights reserved.
393Inflammatory Burden of Truly Asymptomatic Carotid Atheroma with Atherosclerotic Plaquesphagolysosomes produce a T2* susceptibility effect,
visible on as signal voids (Fig. 1).
In contrast, there is a predominant T1 shortening ef-
fect at low concentrations of USPIO in tissue, allowing
potentially better visualisation of the fibrous cap and
suggesting that this contrast agent could be used to
detect not only inflammation within vulnerable pla-
que but also aid in identification of ‘‘safer’’ plaque
with a significant fibrous component.5 Whilst USPIO
imaging relies on a decrease in signal intensity due
to a T2* susceptibility effect, signal enhancement is
predominantly a T1 shortening phenomenon and
may be related to decreased USPIO concentration
within tissue and may well be unrelated to macro-
phage density although further work is required to
determine this relationship more fully.
Currently, there is no consensus on the manage-
ment of the asymptomatic carotid stenosis in patients
undergoing coronary artery bypass grafting (CABG).
The efficacy of carotid endarterectomy (CEA) before
or combined with CABG remains controversial.
Hence it is important to identify those patients at
high risk for significant carotid disease and those
who have vulnerable plaque that is likely to rupture
to aid decision making.
The aim of this studywas to explorewhether there is
a difference in the degree of MR defined inflammation
usingUSPIOparticles, between truly asymptomatic ca-
rotid atheromatous plaque in coronary artery disease
(CAD) free controls and asymptomatic carotid ather-
oma found in patients scheduled to undergo CABG.
The hypothesis is that inflammatory atheroma is a sys-
temic disease and that one inflamed symptomaticFig. 1. Pre (A) and post (B) USPIO imaging showing signific
a patient, awaiting CABG with an asymptomatic carotid stenovascular bed (coronary) is likely to increase the risk of
other arterial vessels to become inflamed (carotid
territory).
Although both groups of patients would be classified
as asymptomatic fromthe standpointof their carotid ste-
nosis, USPIO-enhanced MRI may allow improved risk
stratification of the subgroup of asymptomatic patients
who harbour vulnerable plaque and who are likely to
be at increased risk of developing stroke.Patients & Methods
Subjects
10 patients found to have a significant carotid artery
stenosis on duplex ultrasound criteria during pre-
assessment for CABG surgery were recruited from
a specialist neurovascular clinic in a tertiary referral
centre. Indications for CABG were poorly controlled
angina and congestive heart failure. They were all
asymptomatic from their carotid stenosis and there-
fore had not experienced either a retinal or cortical
transient ischaemic attack or a completed hemispheric
stroke within the previous 6 months in the designated
carotid artery territory. 10 truly asymptomatic indi-
viduals with no documented coronary artery disease
(CAD) had no neurovascular symptoms before imag-
ing and were used as a control group (CAD-free con-
trols). Documentation of CAD status was done not
only by direct questioning of the patient but also
case notes review. This group of patients was detected
as part of screening tests performed when cervicalant signal loss in the post imaging (orange arrowhead) of
sis.
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394 T. Y. Tang et al.bruits were picked up by physical examination and as
an association with other vascular risk factors such as
hypercholesterolaemia, diabetes, peripheral vascular
disease and smoking but no documented CAD. Base-
line demographic characteristics were collected pro-
spectively (Table 1).
The conduct of the MR studies did not cause a delay
in planned surgical intervention. CombinedCABGand
CEA surgery is not routinely performed at our institu-
tion. It should also be noted that routine carotid duplex
ultrasound screening before CABG is also not per-
formed by all surgeons and hence this sample popula-
tion is a non-randomised partially selected group that
may bias the outcome assessment to a degree. This
study was approved by the local ethics committee
and all patients gave written informed consent.
Patients were included if they had a stenosis 50%
on duplex imaging.
Exclusion criteria were 1) prior carotid endarterec-
tomy; 2) prior neck irradiation and 3) contraindica-
tions to MRI.High resolution multi-sequence MR imaging
Multi contrast imaging of both internal carotid arteries
was acquired before and 36 hours after USPIO infusion,Table 1. Baseline characteristics
Group CABG with
asympto-
matic
carotid
stenosis
Truly
asympto-
matic
carotid
stenosis
p-Value*
Number of patients 10 10
Median age (range) 69 (60e79) 74 (65e81)
Male (%) 8 (80) 9 (90) 1.0
Percent luminal
stenosis (SD)
59 (4) 65 (7) 0.03
Normalized wall
index (NWI) (SD)
0.789 (0.09) 0.827 (0.07) 0.16
Body mass index
(BMI) (kg/m2)
27.6 (2.8) 26.1 (4.3) 0.38
Hypertension (%) 10 (100) 7 (70) 0.21
Diabetes (%) 5 (50) 2 (20) 0.35
Peripheral vascular
operations (%)
4 (40) 2 (20) 0.63
Current or ex-smoker (%) 7 (70) 3 (30) 0.18
Hypercholesterolemia (%) 6 (60) 5 (50) 1.0
Cholesterol mmol/L
(SD)
4.8 (0.84) 4.3 (1.31) 0.32
HDL cholesterol
mmol/L (SD)
1.32 (0.18) 1.22 (0.41) 0.49
C-reactive protein
mg/L (SD)
3.45 ( 2.06) 1.9 (0.83) 0.04
Statin use (%) 10 (100) 8 (80) 0.47
Anti-platelet agent (%) 9 (90) 7 (70) 0.58
* p-Values are presented to provide an indication as to the degree
of difference between the two groups. P-values greater than 0.05
should not be interpreted as evidence of ‘no difference’.
Eur J Vasc Endovasc Surg Vol 35, April 2008using a 1.5T MRI system (Signa HDx, GE Healthcare
Technologies, Milwaukee, WI) and a 4-channel phased
array neck coil (PACC, Machnet BV, Elde, The Nether-
lands). Movement artefact was minimised using
a dedicated vacuum e based head restraint system
(VAC-LOK Cushion, Oncology Systems Limited, UK)
to fix the head and neck in a comfortable position and
allow close apposition of the surface coils. The imaging
protocolhasbeenpreviouslydescribed indetail6 and in-
cluded ECG-gated, black blood (BB), fast spin-echo se-
quences with imaging parameters modified to yield
T1-weighted and intermediate and heavily T2-weighted
images for characterising plaque structure. A T2*-
weighted gradient e echo based spiral sequence with
a quadruple inversion recovery preparation was uti-
lised to null the signal from blood pre- and post USPIO.Quantitative image analysis
Pre- and post USPIO MR images were manually co-
registered according to plaque morphology and
distance from the carotid bifurcation at the time of im-
aging. Images were manually segmented into quad-
rants using pre-defined rules and the luminal blood
pool was excluded from the analysis, (CMR Tools,
London, UK). The segmentation protocol was de-
signed to minimise inter-observer error.
Signal intensities in each quadrant were normalised
to the adjacent sternocleidomastoid muscle pre- and
post USPIO. Each quadrant was manually delineated
as a region of interest (ROI) and mean signal pre and
post-USPIO infusion was calculated (Fig. 2). Positive
USPIO e enhanced MRI of carotid plaque was defined
arbitrarily as a signal decrease of more than or equal to
10% in 2 or more quadrants between pre and 36 hours
posteUSPIO imaging. Thiswasdeterminedby two ex-
perienced independent readers (TT & SPSH) and con-
firmed by a consultant neuroradiologist (JHG) who
were blinded to the patient’s group and their demo-
graphics at the time of analysis.
Carotid wall area was calculated as the difference
between total vessel area and lumen area. The nor-
malised wall index (NWI) was calculated by dividing
the wall area by the total vessel area.Statistical Methods
Subject characteristics including demographic infor-
mation and risk factors for atherosclerotic disease
were compared between groups. Fisher’s exact test
was used for frequency counts, and unequal variance
t-test for continuous measurements.
Fig. 2. Principles of quadrant analysis to measure normalised signal change post USPIO infusion.
395Inflammatory Burden of Truly Asymptomatic Carotid Atheroma with Atherosclerotic PlaquesA statistical model has been previously developed
which explicitly models the correlation between sig-
nal loss in different quadrants within a slice, and dif-
ferent slices within a plaque and also accounts for any
dependence or correlation between multiple measure-
ments made on a single patient.5 Furthermore, this
model allowed quantification of the mean signal
change and provided a method for testing for differ-
ences between groups and controlling the type-I error
rate. A simple summary statistic at the patient level
would achieve the necessary independence of data
points, but would not provide the same understand-
ing of the inherent structure of the data.
USPIO-enhanced MRI signal change was analysed
using a repeated measures model with USPIO-
enhanced MRI signal change as the outcome variable.
The group in question (CABG carotid/truly asymp-
tomatic) was fitted as a fixed effect and patient as
a random effect. No other covariates were considered.
Slice and quadrant were used to define the within-
patient correlation within each side. Estimates of
signal change within each side were calculated with
appropriate 95% confidence intervals adjusting for
the correlation between measurements made on the
same subject. An estimate of the difference between
sides with appropriate 95% confidence interval was
also calculated, together with a p-value testing the hy-
pothesis of no difference between sides. Model as-
sumptions regarding homogeneity of variance were
verified by inspection of residual plots. Distributionalassumptions regarding normality were verified by as-
sessment of normal probability plots. The analysis
was carried out using PROC MIXED in SAS for Win-
dows version 8.2 (SAS Institute, Cary, NC, USA).Results
The analysis included 10 asymptomatic patients with se-
vere CAD and awaiting CABG and 10 truly asymptom-
atic patients with no documented CAD. No patients
were excludedbecauseof poor imagequality.All patients
had risk factors consistentwith severe atherosclerotic dis-
ease. Patient characteristics are presented in Table 1.
Mean stenosis in the plaques of CABG patients was
lower than for those that were completely asymptom-
atic (59% compared with 65%; p¼ 0.03), as measured
by high resolution axial black blood MR imaging.7
Patients had between 3 and 9 MRI slices providing
sectional images of the carotid plaque. This resulted in
a mean of 18.4 quadrants per CABG patient (range
12e36), and 17.6 quadrants per truly asymptomatic
patient (range 12e24). One CABG patient had bilat-
eral carotid disease. Both sides from this patient
were included for analysis. 94% of all quadrants
(173/184) from the CABG group showed USPIO sig-
nal loss (range 87.5%e100% within CABG patients),
while only 24% (43/176) of quadrants from the truly
asymptomatic group showed signal loss (range 0%e
45%). A significantly larger proportion of quadrantsEur J Vasc Endovasc Surg Vol 35, April 2008
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the truly asymptomatic population ( p< 0.001) (see
Fig. 3).
According to the repeated measures model de-
scribed earlier, the carotid plaques from the CABG pa-
tients showed a significant mean signal intensity
decrease of 16.4% after USPIO infusion (95% CI
10.6% to 22.2%; p< 0.001). The truly asymptomatic
plaques showed a mean signal intensity increase (i.e.
enhancement) after USPIO infusion of 8.4% (95% CI
2.6% to 14.2%; p¼ 0.007). The difference in signal in-
tensity change between the two groups was 24.9%
(95% CI 16.7% to 33.0%; p< 0.001) (see Fig. 4).Fig. 4. USPIO-enhanced MRI signal change for 10 truly
asymptomatic and 10 pre- CABG patients with an asymp-
tomatic carotid stenosis. Boxes show quartiles and median
across quadrants for each patient. Whiskers show minimum
and maximum. Crosses show patient means. Horizontal ref-
erence lines show group means from the repeated measures
model (solid for CABG, dashed for asymptomatic).Discussion
USPIO-enhanced MRI imaging is a promising non-
invasive method to identify high-risk atheromatous
plaque inflammation in humans, in which areas of
focal signal loss on MR imaging have been shown to
correspond to accumulation of iron particles in ex
vivo specimens2,4 USPIO is thought to accumulate
predominantly in activated macrophages and signal
loss on T2* weighted imaging as a result of USPIO up-
take, may be considered to be a surrogate measure of
the extent of inflammation within the plaque.1,5
The thrust of this study was to explore whether or
not there was a difference in the degree of MR defined
inflammation between asymptomatic plaques in pa-
tients awaiting CABG and those in individuals with
a carotid stenosis who were completely asymptomatic
in all vascular territories. The primary findings were
as follows:Fig. 3. Comparison of percentage of quadrants showing sig-
nal loss between the two groups. Boxes show quartiles and
median across patients for each group. Whiskers show min-
imum and maximum.
Eur J Vasc Endovasc Surg Vol 35, April 20081. Patients awaiting CABG had more inflammatory
activity within their carotid atheroma than did
the completely asymptomatic cohort as demon-
strated by normalized signal loss in significantly
more quadrants and a significant mean signal in-
tensity decrease after USPIO infusion, despite
a mean lower degree of luminal stenosis (59% ver-
sus 65%).
2. Completely asymptomatic individuals had signifi-
cantly more quadrants with signal enhancement,
possibly implying a larger fibrous cap component
and hence possibly greater plaque stability. How-
ever, there was also a subset of quadrants showing
signal loss too.
The results of this study support previous work
that USPIO may be useful in the assessment of inflam-
matory activity in asymptomatic carotid atheros-
clerotic plaques.6 We have previously shown that
almost 100% of symptomatic carotid plaques demon-
strated USPIO uptake in contrast with decreased up-
take in any asymptomatic contralateral lesions.5 In
turn, the contralateral side to the symptomatic steno-
sis showed more USPIO enhanced MR defined in-
flammation than the truly asymptomatic plaques.6
These findings are consistent with the hypothesis
that inflammatory atheroma is a systemic disease
and suggests that one inflamed symptomatic vascular
bed is likely to increase the likelihood that other arte-
rial vessels to become or are inflamed. Furthermore,
the results suggest that the carotid territory is more
likely to take up USPIO if another vascular territory
397Inflammatory Burden of Truly Asymptomatic Carotid Atheroma with Atherosclerotic Plaquesis symptomatic. Biochemical and histopathological
studies have found that active inflammation in acute
coronary syndrome is not confined to the ‘‘culprit’’
coronary plaque but is part of a widespread activation
of the coronary tree.8,9 Other clinical studies have sug-
gested that a status of panvascular active inflamma-
tion exists.10,11 Furthermore, plaque instability may
not be confined to a single ‘‘culprit’’ lesion nor be
within only one vascular territory. A higher frequency
of complex carotid plaques as detected by ultrasonog-
raphy were found in patients with unstable angina
and increased C-reactive protein levels.12 Signs of ca-
rotid plaque instability on MR imaging have been also
associated with clinical symptoms.13
Furthermore, the results point at the possibility for
amore accelerated disease progress that couldpartly ex-
plain thedifference inprognosis of a culprit lesion if part
of a more widespread phenomenon versus being a soli-
tary manifestation. Evidence for this has been present
for some time e the prognosis of non-invasively as-
sessed atherosclerotic carotid stenosis, peripheral artery
disease and ischaemic heart disease are likely to be de-
pendent on the concomitant disease burden.14
In the present study, inflammation as defined by
signal loss on USPIO enhanced MR imaging was
more frequently observed in patients with active
CAD. This was also reflected in the difference in
CRP levels between the two groups. Systemic activa-
tion of the inflammatory system might be a pathologi-
cal process linking both coronary and carotid plaque
vulnerability.
However this hypothesis can only be validated fol-
lowing large scale prospective natural history studies.
Unfortunately at the time of writing no such studies
exist and therefore although this study represents in-
teresting preliminary work, it requires validation not
only in terms of a larger number of patients but also
corroborative natural history data. Were such valida-
tion to be possible, there might be a strong argument
in the future for following a group of CABG patients
prospectively in a future USPIO study to determine
the number of cerebrovascular events that occur peri-
operatively. An interesting question is whether or not
there is a correlation between the degree of USPIO up-
take pre-operatively and the development of stroke
subsequently e only a large longitudinal study would
likewise be able to answer this question. This is highly
clinically relevant as patients awaiting coronary revas-
cularisation who are found to have a degree of carotid
artery stenosismay still be offered CEA prior to CABG.
It remains unclear whether this is clinically appropri-
ate or whether a synchronous procedure is indicated.
At first glance, statistical analysis of the patient
characteristic data reveals a significant differencebetween the degree of stenosis between the CABG
and truly asymptomatic groups (59% versus 65% re-
spectively). Thus it should naturally follow that the
higher the stenosis the greater the inflammation and
therefore the higher the risk. This in fact was not the
case since the group with the least amount of stenosis
(i.e. CABG group) had the highest degree of USPIO e
defined inflammation, quite contrary to intuitive and
conventional expectations. This was also seen in a pre-
vious USPIO study imaging asymptomatic carotid
disease, whereby USPIO attributable signal loss was
found to be greater in the asymptomatic plaques con-
tralateral to the symptomatic stenosis than in the com-
pletely asymptomatic ones, despite the fact that the
atheroma on the contralateral side had a significantly
lower degree of stenosis than the truly asymptomatic
cohort.6 Thus, USPIO uptake may be a factor able to
enhance risk stratification when compared with lumi-
nal stenosis alone.Study limitations
Limitations of the study include, by design, that there
was no corroborative evidence from histology al-
though Trivedi et al. have shown that there is good
correlation and co-localisation of USPIO uptake on
MRI and USPIO staining of activated macrophages
within carotid plaque.2 Quantification of macrophage
burden by USPIO signal change remains unclear and
the technique described in this study in quantifying
signal change is by no means definitive as numbers
who have had USPIO infusions are still small. Little
is known of the natural history of USPIO uptake in
asymptomatic atheroma. A longitudinal study may
help answer whether inflammatory burden alters
over time or whether large USPIO uptake can indeed
be eventually correlated with patient ischaemic
events.
Another shortcoming of the study is that the sam-
ple size used is too small to make any statements sug-
gesting similarity of the two groups because of the
risk of a type II statistical error. Also there is no formal
documentation of the extent of coronary artery dis-
ease burden in terms of angiographic investigations
or stress evaluations of the truly asymptomatic indi-
viduals. However, we would not have been able to
clinically or ethically justify this.Conclusions
Asymptomatic carotid plaques in patients awaiting
CABG seem to demonstrate more inflammation
than those of truly asymptomatic individuals.Eur J Vasc Endovasc Surg Vol 35, April 2008
398 T. Y. Tang et al.Inflammatory activity may be a significant risk factor
in asymptomatic disease and may help risk stratify
this patient cohort in the future.
Stroke is just one of the many silos of a larger vas-
cular problem. Earlier and more refined global vascu-
lar risk estimation should lead to advances in our
understanding of ways to modify risk. MR imaging
of the carotid artery may serve as a window to image
the entire cardiovascular system and be able to iden-
tify ‘‘vulnerable’’ plaques and patients who are at
high risk of developing future coronary and cerebro-
vascular events.
Acknowledgments
The authorswish to thankMEGaunt and JRBoyle for contrib-
uting their patients to the study, the MR radiographers, Ilse
Joubert and Ruth Beavon for their hard work and Tim Baynes,
Specialist Research Nurse, for his dedication and support.References
1 ROSS R. Atherosclerosis e an inflammatory disease. N Engl J Med
1999;340(2):115e126.
2 TRIVEDI RA, MALLAWARACHI C, U-KING-IM JM, GRAVES MJ,
HORSLEY J, GODDARD MJ et al. Identifying inflamed carotid pla-
ques using in vivo USPIO-enhanced MR imaging to label plaque
macrophages. Arterioscler Thromb Vasc Biol 2006;26(7):1601e1606.
3 TRIVEDI RA, U-KING-IM JM, GRAVES MJ, KIRKPATRICK PJ, GILLARD JH.
Noninvasive imaging of carotid plaque inflammation. Neurology
2004;63(1):187e188.
4 TRIVEDI RA, U-KING-IM JM, GRAVES MJ, CROSS JJ, HORSLEY J,
GODDARDMJ et al. Invivodetectionofmacrophages inhumancarotid
atheroma: temporal dependence of ultrasmall superparamagnetic
particles of iron oxide-enhanced MRI. Stroke 2004;35(7):1631e1635.
5 TANG T, HOWARTH SP, MILLER SR, TRIVEDI R, GRAVES MJ, KING-IM JU
et al. Assessment of inflammatory burden contralateral to theEur J Vasc Endovasc Surg Vol 35, April 2008symptomatic carotid stenosis using high-resolution ultrasmall,
superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37(9):
2266e2270.
6 TANG TY, HOWARTH SP, MILLER SR, GRAVES MJ, UK-I JM,
TRIVEDI RA et al. Comparison of the inflammatory burden of truly
asymptomatic carotid atheroma with atherosclerotic plaques
contralateral to symptomatic carotid stenosis: an ultrasmall
superparamagnetic iron oxide enhanced magnetic resonance
study. J Neurol Neurosurg Psychiatry 2007.
7 U-KING-IM JM, TRIVEDI RA, SALA E, GRAVES MJ, GASKARTH M,
HIGGINS NJ et al. Evaluation of carotid stenosis with axial high-
resolution black-blood MR imaging. Eur Radiol 2004;14(7):
1154e1161.
8 BUFFON A, BIASUCCI LM, LIUZZO G, D’ONOFRIO G, CREA F, MASERI A.
Widespread coronary inflammation in unstable angina. N Engl J
Med 2002;347(1):5e12.
9 SPAGNOLI LG, BONANNO E, MAURIELLO A, PALMIERI G, PARTENZI A,
SANGIORGI G et al. Multicentric inflammation in epicardial coro-
nary arteries of patients dying of acute myocardial infarction.
J Am Coll Cardiol 2002;40(9):1579e1588.
10 HENDERSON RD, ELIASZIW M, FOX AJ, ROTHWELL PM, BARNETT HJ.
Angiographically defined collateral circulation and risk of stroke
in patients with severe carotid artery stenosis. North American
Symptomatic Carotid Endarterectomy Trial (NASCET) Group.
Stroke 2000;31(1):128e132.
11 COHEN A, TZOURIO C, BERTRAND B, CHAUVEL C, BOUSSER MG,
AMARENCO P. Aortic plaque morphology and vascular events:
a follow-up study in patients with ischemic stroke. FAPS Inves-
tigators. French Study of Aortic Plaques in Stroke. Circulation
1997;96(11):3838e3841.
12 LOMBARDO A, BIASUCCI LM, LANZA GA, COLI S, SILVESTRI P,
CIANFLONE D et al. Inflammation as a possible link between coro-
nary and carotid plaque instability. Circulation 2004;109(25):
3158e3163.
13 SAAM T, YUAN C, CHU B, TAKAYA N, UNDERHILL H, CAI J et al.
Predictors of carotid atherosclerotic plaque progression as mea-
sured by noninvasive magnetic resonance imaging. Atherosclero-
sis 2006.
14 OGREN M, HEDBLAD B, ISACSSON SO, JANZON L, JUNGQUIST G,
LINDELL SE. Non-invasively detected carotid stenosis and ischae-
mic heart disease in men with leg arteriosclerosis. Lancet 1993;
342:1138e1141.
Accepted 26 October 2007
Available online 2 January 2008
